Cyromazine Premix Veterinary Grade API is received as a crystalline solid with a melting point of **223°C to 226°C**, an aqueous solubility of approximately **11 g/L at 20°C**, and an octanol/water partition coefficient below **1.0**. These physical properties direct processing toward aqueous granulation and dry blending rather than solvent-based dissolution. The low partition coefficient reduces lipid-phase migration in feed and capsule formulations, but it also imposes dissolution testing in acidified or hydroalcoholic media when high-dose concentrations approach solubility limits. Manufacturing lines that handle the API as a fine powder should control relative humidity below **60%** and should use stainless steel contact surfaces because triazine derivatives can undergo metal-catalyzed degradation at elevated temperature and alkaline pH. The API is typically pin-milled or jet-milled to a volume median diameter between **5 µm and 40 µm** depending on dosage form. For low-dose dry blends, a narrower distribution below **20 µm** improves content uniformity but increases dust exposure and requires local exhaust ventilation, as well as dust-tight transfer systems.Feed-through premix granulation for poultry and pig manure fly control uses cyromazine at low inclusion rates so that the active ingredient is excreted in manure at larvicidal concentrations. Premix concentrations are commonly prepared at **1% w/w to 10% w/w** on a lignocellulosic carrier such as ground corn cob or rice hulls; final feed addition is label-dependent and typically falls between **1.5 mg/kg and 5.0 mg/kg of complete feed**, subject to regional authorization. The API is first dry-blended with colloidal silicon dioxide at **0.25% w/w to 0.50% w/w** as a flow aid and then mixed with the carrier in a ribbon blender for **10 to 15 minutes**. Spray granulation applies water or a binder solution at **6% w/w to 8% w/w** of carrier mass through a twin-fluid nozzle with atomizing air pressure between **1.5 bar and 2.5 bar**. The granulated premix is dried on a fluid bed dryer at **50°C to 55°C** until the moisture content reaches **10% w/w to 12% w/w**. The dried granules are passed over a **710 µm** sieve and then over a **150 µm** sieve to remove coarse trains and fine dust. Metering augers must be calibrated for the granulated premix bulk density of **0.55 g/mL to 0.75 g/mL**, because density drift changes the mass delivered per auger revolution. Homogeneity is assessed by taking **10** sampling points per batch and assaying each with HPLC-UV after extraction in **50:50 v/v** methanol-water; the coefficient of variation is typically held below **5.0%**. The process intent aligns with **Regulation (EC) No 1831/2003** for feed additives and **21 CFR 225.1** for medicated feed manufacturing. Because cyromazine is stable at common conditioning temperatures of **70°C to 85°C**, the premix may be incorporated before steam pelleting, but post-pelleting liquid addition is preferred when the feed also contains heat-labile enzymes or probiotics.

How Does pH Drift in Oral Drench Solutions Affect Benzyl Alcohol Preservation?

Oral drench solutions and spray-on dilution concentrates for sheep blowfly control use cyromazine at **500 mg/L to 10 g/L** in aqueous vehicles. Since the API dissolves to approximately **11 g/L at 20°C**, concentrations above this limit require a co-solvent system of propylene glycol at **10% v/v to 20% v/v** or pH adjustment into the weakly acidic range. Drench solutions are compounded in stainless steel tanks with overhead impellers running at **100 rpm to 150 rpm**, and the API is added slowly to avoid floating on the meniscus and forming a gel-like hydrate layer. The vehicle is preserved with sodium benzoate at **0.1% w/w** and potassium sorbate at **0.1% w/w** when the pH is maintained at **4.0 to 4.5**; above **pH 5.5** the benzoate ionizes and loses antimicrobial activity, so benzyl alcohol at **0.5% v/v** is substituted. The pH of the final solution is measured at **25°C** with a calibrated electrode, and the specification is set at **4.0 to 4.8**, because higher pH values reduce the chemical stability of cyromazine through hydrolysis of the amino-substituent on the triazine ring. Rotary piston filling machines handle the solution at **20°C to 25°C** with filling speeds below **60 cycles per minute**; excessive speed causes foaming due to trace surfactant-like impurities in the API. Filled high-density polyethylene containers are induction-sealed and stored at **25°C** with protection from light. In a sheep drenching operation, the dose is delivered by a drench gun calibrated to **2.5 mL per 25 kg body weight**, and calibration checks are performed by water displacement every **500** animals. For spray-on application to fleece, the concentrate is diluted **1:1000** with water immediately before use and passed through a **200 µm** screen to prevent nozzle obstruction.

When Tablet Compression Replaces In-Feed Delivery in Small Ruminants

Tablets containing cyromazine are prepared in veterinary compounding facilities when individual oral dosing is required in sheep or goats and feed-based delivery is not practical. Direct compression of the crystalline API is unreliable because the plate-like particles exhibit high elastic recovery and produce tablet capping at compression forces above **8 kN**. A wet granulation route is therefore used: the API is pre-blended with microcrystalline cellulose at **20% w/w to 30% w/w**, lactose monohydrate at **25% w/w to 35% w/w**, and croscarmellose sodium at **1.0% w/w to 2.0% w/w**. Binding is performed with a hypromellose solution at **2.5% w/w to 4.0% w/w** in a high-shear granulator with impeller speed **200 rpm to 300 rpm** and chopper speed **1500 rpm to 1800 rpm**. The wet mass is dried in a fluid bed dryer at **50°C to 55°C** until loss-on-drying by **USP <731>** is **1.5% w/w to 2.5% w/w**. After dry milling through a **1.0 mm** screen, the granules are lubricated with magnesium stearate at **0.5% w/w** for **3 minutes** in a V-blender. Compression is performed on a rotary tablet press with **8 mm to 10 mm** round concave tooling at a compression force of **8 kN to 14 kN** and turret speed **20 rpm to 30 rpm**. Target tablet hardness is **40 N to 70 N**, and friability measured by **USP <1216>** is not more than **0.8%**. Content uniformity follows **USP <905>** with acceptance value not more than **15.0**. Dissolution is evaluated by **USP <711>** apparatus II at **50 rpm** in **900 mL** of **pH 1.2** buffer; the Q value applied during development is **75% dissolved at 45 minutes**. The tablets are packaged in PVC-PVDC blisters and stored below **25°C**; storage above **40°C** with uncontrolled humidity can cause moisture uptake and surface mottling. Because the API has low lipid solubility, food effects are not considered significant, but co-administration with high-fat oral drenches may reduce the rate of gastric emptying and delay absorption.

Sterile Parenteral Thermal Degradation and Endotoxin Control

Commercial injectable cyromazine dosage forms for food-producing animals are not widely documented in public pharmacopoeial monographs, and published production-scale data for this specific configuration is limited. When sterile aqueous solutions are developed for experimental or veterinary use, the API is dissolved in water for injection at **10 mg/mL to 50 mg/mL** and titrated to **pH 4.5 to 5.5** with citrate or acetate buffer. The solution is filtered through a **0.22 µm** polyethersulfone membrane and aseptically filled into **Type I** borosilicate glass vials with nitrogen overlay. Terminal moist-heat sterilization at **121°C for 15 minutes** is generally avoided because the triazine ring undergoes hydrolysis under sustained high-temperature aqueous conditions; if terminal sterilization is required, the cycle should be limited to **121°C for 10 minutes** and the degradation profile confirmed by HPLC-MS. Endotoxin release testing follows **USP <85>** with a limit appropriate to the intended dose and route; sterility testing follows **USP <71>** or **Ph. Eur. 2.6.1**. The finished solution is stored at **2°C to 8°C** in a light-protected carton; storage at **25°C** for extended periods increases the risk of subvisible particle growth measured by light obscuration using **USP <787>**. Preservative-free single-dose vials are designed for withdrawal within **24 hours** of first stopper puncture. Because no published residue depletion data for injectable cyromazine in cattle or sheep is available, withdrawal period establishment must follow regional residue guidelines and is based on the detection of cyromazine and melamine as marker residues by LC-MS/MS in edible tissues.

Dosage form	Critical process parameter	Typical range or limit	Test designation
Feed premix granules	Moisture after fluid bed drying	10% w/w to 12% w/w	USP <731>
Oral drench solution	Final pH	4.0 to 4.8	USP <791>
Tablets	Friability	≤0.8%	USP <1216>
Injectable solution	Sterility	No growth	USP <71>
Soluble powder	Bulk density	0.45 g/mL to 0.65 g/mL	USP <616>
Capsules	Disintegration time	≤15 min	USP <701>
Wettable powder	Wet sieve retention at 44 µm	≤0.1% w/w	CIPAC MT 185

Compliance requirement	Applicable dosage forms	Reference
Content uniformity	Tablets, capsules	USP <905>
Dissolution	Tablets, capsules	USP <711>
Microbial limits	Oral drench solutions, soluble powders	USP <61>/<62>
Endotoxin	Injectable solutions	USP <85>
Sterility	Injectable solutions	USP <71>
Medicated feed manufacturing	Feed premix granules	21 CFR 225.1
Feed additive authorization	Feed premix granules	Regulation (EC) No 1831/2003

In drinking water medication, soluble powders are produced by blending cyromazine with anhydrous dextrose or lactose monohydrate and a citrate buffer to target a final solution pH of **3.5 to 4.5**. The API is pre-sieved through a **425 µm** mesh and blended in a double-cone mixer at **60% to 70%** of nominal volume for **15 to 20 minutes**. The bulk density of the final powder is checked by **USP <616>**, with an acceptance range of **0.45 g/mL to 0.65 g/mL**, because denser powders segregate in storage bins and lighter powders produce dust during transfer. The powder is filled into moisture-resistant foil-lined sachets; in-use reconstitution prepares a stock solution of **1 g/L to 5 g/L** before proportional dosing into drinking water lines at **1:100 to 1:200** dilution. The resulting drinking water solution remains stable for **24 hours at 25°C** and for **48 hours at 2°C to 8°C** when protected from light. In poultry house water systems, the pH of the final drinking water should remain below **5.0**, because alkaline water above **pH 7.0** reduces the concentration of intact cyromazine in the water line and lowers the amount of active ingredient excreted into manure. In-line conductivity sensors calibrated from **0.0 mS/cm to 2.0 mS/cm** are used to verify proportioner dosing accuracy, and drinker lines are flushed before and after medication to prevent biofilm accumulation. A stock solution prepared with hard water containing calcium above **200 mg/L** may develop turbidity due to citrate-calcium complexes; in such cases, a water softener or a lower stock concentration is used.Hard gelatin capsule filling for cyromazine is specified when a compounding veterinarian requires a discrete dose for sheep or goats and commercial tablets are not available. Capsule strengths typically range from **50 mg to 200 mg** in **size 3** or **size 4** hard gelatin shells. The dry blend consists of cyromazine, lactose monohydrate, and pregelatinized starch; the API is first forced through a **180 µm** screen and geometrically diluted in **5** equal portions with the diluent before being transferred to the hopper of a semi-automatic capsule machine. Fill density is monitored in the range **0.55 g/mL to 0.70 g/mL**, and the machine pin setting is validated by weight uniformity testing on **20** capsules per **15 minutes** of filling. Disintegration testing follows **USP <701>** in **900 mL** of water at **37°C**, with complete disintegration required within **15 minutes**. Dissolution uses **USP <711>** apparatus I at **100 rpm** in **900 mL** of **0.01 M hydrochloric acid**; a Q value of **75% at 45 minutes** is applied during development. Hard gelatin shells remain dimensionally stable at **25°C and 60% relative humidity**, but exposure to temperatures above **40°C** or to aldehydes from certain packaging adhesives triggers shell cross-linking and delayed disintegration. Packages are PVC-PVDC blisters with a desiccant canister when the local annual average relative humidity exceeds **65%**. Since published residue depletion data for cyromazine capsules in food-producing animals is limited, use in lactating animals should be restricted and withdrawal periods assigned under veterinary supervision in accordance with regional residue regulations.

Dispersing Cyromazine Wettable Powder in Hard Water Tanks

Wettable powder concentrates containing cyromazine at **50% w/w** are used for sheep blowfly prevention by spray application to the fleece after dilution to **500 mg/L to 1000 mg/L** active concentration. The concentrate is manufactured by blending the API with kaolin or precipitated silica, sodium lauryl sulfate at **1% w/w to 2% w/w**, and sodium lignosulfonate at **3% w/w to 5% w/w**, followed by air classifier milling to a median particle size of **5 µm to 10 µm**. Fine milling is critical because particles larger than **44 µm** settle rapidly in the spray tank and produce uneven active distribution on the fleece; retention on a **44 µm** wet sieve is specified at less than **0.1% w/w** of the original solids after dispersing in **water at 30°C** for **2 minutes**. Hard water compatibility is improved by the addition of citric acid at **0.1% w/w to 0.3% w/w**, which chelates calcium and magnesium ions and prevents the collapse of the lignosulfonate dispersant layer. Spray application is performed through backpack sprayers at **300 kPa to 400 kPa** with flat-fan nozzles that deliver coarse droplets; foam build-up in the tank is controlled by the low surfactant content and by anti-foam addition at **0.05% v/v** when recirculation is vigorous. The diluted suspension should be used within **4 hours** under continuous agitation; re-suspension tests after **24 hours** are used to verify long-term tank stability. Applicator exposure is controlled by the API's low dermal penetration and by standard protective equipment such as nitrile gloves and coveralls; spray drift to adjacent water bodies should be prevented by respecting a **5 m** buffer zone. The residual larvicidal activity on fleece depends on fleece condition, rainfall, and lanolin composition and must therefore be confirmed under regional field conditions rather than extrapolated from laboratory contact bioassays alone.